Vaccine Technologies and Platforms for Infectious Diseases: Current Progress, Challenges, and Opportunities
Vaccination is a key component of public health policy with demonstrated cost-effective benefits in protecting both human and animal populations. Vaccines can be manufactured under multiple forms including, inactivated (killed), toxoid, live attenuated, Virus-like Particles, synthetic peptide, polys...
Main Authors: | Majed Ghattas, Garima Dwivedi, Marc Lavertu, Mohamad-Gabriel Alameh |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-12-01
|
Series: | Vaccines |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-393X/9/12/1490 |
Similar Items
-
Approaches of dengue control: vaccine strategies and future aspects
by: Runa Akter, et al.
Published: (2024-02-01) -
Rational Development of Live-Attenuated Zika Virus Vaccines
by: Awadalkareem Adam, et al.
Published: (2023-01-01) -
New Points of Departure for More Global Influenza Vaccine Use
by: Irina Kiseleva
Published: (2020-07-01) -
Recent Development of Ruminant Vaccine Against Viral Diseases
by: Sk Mohiuddin Choudhury, et al.
Published: (2021-11-01) -
Bacterial vaccines in poultry
by: Nagwa S. Rabie, et al.
Published: (2020-01-01)